Scandinavian Journal of Pain
Volume 1, Issue 3 , Pages 120-121 , July 2010

Long-term low-dose transdermal buprenorphine therapy for chronic noncancer pain

  • Petter C. Borchgrevink

      Affiliations

    • Department of Pain and Complex Disorders, St. Olav University Hospital, Trondheim, Norway
    • Pain and Palliation Research Group, Department of Circulation and Medical Imaging, Faculty of Medicine, Norwegian University of Science and Technology, Trondheim, Norway
    • Corresponding Author InformationCorrespondence address: Department of Pain and Complex Disorders, St. Olav University Hospital, Trondheim, Norway.

References 

  1. Breivik H, Ljosaa TM, Stengaard-Pedersen K, Bliddal H, Persson J, Aro H, et al. A 6-months, randomised, placebo-controlled evaluation of efficacy and tolerability of a 7-day buprenorphine transdermal patch in osteoarthritis patients naïve to potent-opioids. Scand J Pain. 2010;1:122–141
  2. Peloso PM, Fortin L, Beaulieu A, Kamin M, Rosenthal N Protocol TRP-CAN-1 Study Group. Analgesic efficacy and safety of tramadol/acetaminophen combination tablets (Ultracet) in treatment of chronic low back pain: a multicenter, outpatient, randomized, double blind, placebo controlled trial. J Rheumatol. 2004;31:2454–2463
  3. Noble M, Treadwell JR, Tregear SJ, Coates VH, Wiffen PJ, Akafomo C, et al. Long-term opioid management for chronic noncancer pain. Cochrane Database Syst Rev. 2010;(1):CD006605.pub2
  4. Kalso E, Edwards JE, Moore A, McQuay HJ. Opioids in chronic non-cancer pain: systematic review of efficacy and safety. Pain. 2004;112:372–380
  5. Johnson RE, Fudala PJ, Payne R. Buprenorphine: considerations for pain management. J Pain Symptom Manage. 2005;29:297–326
  6. Vadivelu N, Hines RL. Buprenorphine: a unique opioid with broad clinical applications. J Opioid Manag. 2007;3:49–58
  7. Skurtveit S, Furu K, Kaasa S, Borchgrevink PC. Introduction of low dose transdermal buprenorphine – did it influence use of potentially addictive drugs in chronic non-malignant pain patients?. Eur J Pain. 2009;13:949–953
  8. Nordbø A, Skurtveit S, Borchgrevink PC, Kaasa S, Fredheim O. Is transdermal buprenorphine for chronic non-malignant pain used long term without co-medication with other potentially addictive drugs?. Abstract at congress of the new Scandinavian Association for the Study of Pain. Oslo, April 8–10, 2010, Scand J Pain. 2010;1:xx–xx
  9. Breivik H. Appropriate and responsible treatment of cncp with opioids. Eur J Pain. 2003;7:379–380

PII: S1877-8860(10)00081-9

doi: 10.1016/j.sjpain.2010.05.034

Scandinavian Journal of Pain
Volume 1, Issue 3 , Pages 120-121 , July 2010

Article Tools